Pricing Log in Create free account

BioCardia, Inc. (BCDA) vs NewcelX Ltd. (NCEL)

BioCardia, Inc. and NewcelX Ltd. are both Biotechnology companies. NewcelX Ltd. is the larger, with a market value of $15.6M against $13.5M — 1.2× the size. Across the 10 metrics below, BioCardia, Inc. leads on 6 and NewcelX Ltd. on 4.

Valuation

Metric BCDA NCEL Biotechnology median
P/E n/m n/m 10.60
P/S 24.58 n/m 9.40
P/B 3.90 5.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 28.74 n/m 9.02
Earnings yield (87.99%) (56.25%) (32.88%)
Free cash flow yield (71.97%) (16.18%) (23.13%)

Profitability

Metric BCDA NCEL Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,803.19%) 0.00% (51.96%)
Return on assets (214.47%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCDA NCEL Biotechnology median
Revenue growth (TTM) 0.71% — 6.76%
EPS growth (last fiscal year) 57.59% 11.18% 29.88%
Revenue growth, 5-year CAGR 26.89% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCDA NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 2.09 0.40 4.97
Net debt to EBITDA 0.30 0.74 1.01

Dividend

Metric BCDA NCEL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCDA NCEL Biotechnology median
Market cap 13.47m 15.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack